Confusion reigns over Covishield on UK's travel advisory as India not on eligibility list
London, (PTI): There is confusion over the UK government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.
The UK's Department of Health and Social Care (DHSC) have said on Wednesday that they are unable to confirm this and will require further clarifications even though the advisory states: Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines.
There has been widespread condemnation of the Serum Institute of India manufactured vaccines not being included in a list of eligible COVID-19 vaccines recognised under Britain's reviewed international travel norms, effective from October 4.
From October 4, England's current traffic light system of red, amber and green countries based on levels of COVID-19 risk will be scrapped and replaced with one red list only. However, there is a lack of clarity over whether Indians vaccinated with any vaccines in India including Covishield fall within the UK's eligibility criteria or not.
We have to see how it goes. But if we do not get satisfaction we would be within our rights to impose reciprocal measures, Foreign Secretary Harsh Vardhan Shringla said in response to a question on the issue in New Delhi on Tuesday.
The basic issue is that here is a vaccine, Covishield, which is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK at the request of the government of the UK. We understand that this is being used under the national health system, and, therefore, non-recognition of Covishield is a discriminatory policy and does impact those of our citizens travelling to the UK, he said.
Covishield and other Indian vaccines being covered as eligible would mean that a pre-departure PCR test is no longer required as long as vaccinated travellers pre-book a day two test post-arrival in England and complete the compulsory passenger locator form in advance.
From October 4, travellers from 17 additional countries with eligible vaccines, including Australia, Japan, Singapore and Malaysia, will fall under the UK's list of recognised jabs of Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines. The DHSC has said this list is reviewed fortnightly.
So far it means, under the new rules from October 4, travellers from India must take a COVID test three days before departure and book in advance for two COVID tests to be taken upon arrival in England. On arrival in England, the passengers must self-isolate in the place they have confirmed on their passenger locator form for 10 days.
A privately paid-for "Test to Release" option does exist at day five, which allows an early end to the 10-day quarantine with a negative PCR test.
The Indian government has said it is working with several countries to recognise India's vaccine certification on a mutual reciprocal basis .
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
One dead, 5 injured in explosion at firecracker factory in Maharashtra's Palghar
Palghar (PTI): A worker was killed and five others were seriously injured after an explosion ripped through a firecracker factory in Maharashtra's Palghar district on Tuesday, police said.
Two persons were arrested in connection with the incident, said an official.
Earlier, the administration had put the death toll at two, but a corrected statement in the evening said a male worker died while a woman with 80 per cent burns was undergoing treatment.
The tragedy follows the blast at a firecracker factory in Tamil Nadu which claimed 23 lives and left many injured on Sunday.
The explosion occurred around 12 pm on Tuesday at a firecracker manufacturing unit operating out of a tin shed inside an old farmhouse at Konsai village of Wada taluka, said Vivekanand Kadam, chief of the civic disaster management cell.
As many as 35 workers, mostly women, were engaged in manufacturing 'twine bombs' (thread-bound crackers) at the time, he said.
"The explosion took place when a chemical mixing process was underway, killing one worker on the spot, and leaving a woman -- Monica Sachin Padwale (30) -- with 80 per cent burn injuries," an official from Wada police station said. The woman was later shifted to a Mumbai hospital.
The deceased worker was identified as Bhavesh Dileep Vavare (35).
Monica Mahendra Jadhav (30), Jagruti Jagdish Gavate (27), Pratibha Pratap Pawar (30) and Monica Mohan Vardi (25) also sustained serious injuries and were undergoing treatment at Wada Rural Hospital.
"Fire services and police reached the spot immediately to oversee rescue operations. The blaze following the explosion was quickly brought under control by the fire brigade," the official said.
As per preliminary investigations, raw materials were brought from outside to the unit which had begun operations on April 10, and daily-wage workers from nearby villages including Jamghar, Konsai, Palsai and Alman were employed.
A probe is underway to ascertain if the manufacturing unit possessed necessary licenses and followed safety protocols, the police official said.
"We are probing the exact cause of the fire and possible negligence regarding safety measures at the site," the official said, adding that a search was underway for the owners of the manufacturing unit.
The factory shed collapsed following the blast, sending splinters flying. Body parts of the deceased were found some distance away.
District Superintendent of Police Yatish Deshmukh told PTI that the process of registering an offence against three persons including the shed owner was underway.
The shed owner and another accused were arrested and the police were on the look-out of the third accused.
